The Magnetic Resonance Imaging Evaluation of Doxorubicin Cardiotoxicity
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate MR imaging in subjects receiving
doxorubicin chemotherapy to see if MR can detect heart damage as well as or better than MUGA
scans.
This research study is expected to enroll approximately 10 subjects over 12 months at the
University of Miami / Miller School of Medicine.